Antineoplastic Agents. 465. Structural Modification of Resveratrol: Sodium Resverastatin Phosphate-Reference-Cited by-同舟云学术

Antineoplastic Agents. 465. Structural Modification of Resveratrol: Sodium Resverastatin Phosphate

Published:2002-05-10 Issue:12 Volume:45 Page:2534-2542
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Pettit George R.¹,Grealish Matthew P.¹,Jung M. Katherine¹,Hamel Ernest¹,Pettit Robin K.¹,Chapuis J.-Charles¹,Schmidt Jean M.¹

Affiliation:

1. Cancer Research Institute and Department of Chemistry and Biochemistry, Arizona State University, P.O. Box 872404, Tempe, Arizona 85287-2404, Science Application International CorporationFrederick, National Cancer Institute at Frederick, National Institutes of Health, Frederick, Maryland 21702, and Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, National Institutes of Health, Frederick, Maryland 21702

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm010119y

Reference48 articles.

1. Fluorinated resveratrol and pterostilbene

2. Resveratrol Is a Selective Human Cytochrome P450 1A1 Inhibitor

3. Isolation, Synthesis, and Antiplatelet Aggregation Activity of Resveratrol 3-O-β-d-Glucopyranoside and Related Compounds

Cited by 170 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Small Molecule–Based Medicinal Chemistry Approaches for Neurodegeneration Therapeutics;ChemMedChem;2024-02-29

2. Carboranylphosphines: B9‐Substituted Derivatives with Enhanced Reactivity for the Anchoring to Dendrimers;Chemistry – A European Journal;2024-01-24

3. Recent Developments in Nanoparticle Formulations for Resveratrol Encapsulation as an Anticancer Agent;Pharmaceuticals;2024-01-18

4. Inhibition of ANO1 by Cis- and Trans-Resveratrol and Their Anticancer Activity in Human Prostate Cancer PC-3 Cells;International Journal of Molecular Sciences;2023-01-07

5. Novel combretastatin A-4 derivative containing aminophosphonates as dual inhibitors of tubulin and matrix metalloproteinases for lung cancer treatment;European Journal of Medicinal Chemistry;2022-12